Harnessing mixed chimerism and programmed cell death protein 1/programmed death ligand 1 signaling for transplant tolerance

被引：0
|
作者：
Li, Shuang [2 ]
Zou, Dawei [1 ,3 ]
机构：
[1] Houston Methodist Res Inst, Dept Cardiovasc Sci, Houston, TX USA
[2] Houston Methodist Hosp, Houston Methodist Res Inst, Immunobiol & Transplant Sci Ctr, Dept Surg, Houston, TX USA
[3] Houston Methodist Hosp, Houston Methodist Res Inst, Immunobiol Transplant Sci Ctr, 6670 Bertner Ave,R7-430-3, Houston, TX 77030 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2024年 / 24卷 / 01期
关键词：
T cell; transplant tolerance; mixed chimerism; PD-1/PD-L1; T cell exhaustion; T cell anergy;
D O I：
10.1016/j.ajt.2023.09.016
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：147 / 148
页数：2
相关论文
共 50 条
  • [31] There Is No Unmet Need for Another Programmed Cell Death Protein-1 or Programmed Death-Ligand 1 Inhibitor for Metastatic NSCLC
    Dagogo-Jack, Ibiayi
    Piotrowska, Zofia
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (10) : 1171 - 1174
  • [32] Programmed cell death 1 protein and programmed death-ligand 1 inhibitors in the treatment of nonmelanoma skin cancer: A systematic review
    Choi, Franchesca D.
    Kraus, Christina N.
    Elsensohn, Ashley N.
    Carley, Sama K.
    Lehmer, Larisa M.
    Nguyen, Rebecca T.
    Linden, Kenneth G.
    Shiu, Jessica
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (02) : 440 - 459
  • [33] A critical role for the programmed death ligand 1 in fetomaternal tolerance
    Guleria, I
    Khosroshahi, A
    Ansari, MJ
    Habicht, A
    Azuma, M
    Yagita, H
    Noelle, RJ
    Sayegh, MH
    JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (02): : 231 - 237
  • [34] Programmed Cell Death 1 and Programmed Cell Death Ligand 1 Expression in Extranodal NK/T-Cell Lymphoma
    Jung, Ho Young
    Kim, Wook Youn
    Kim, Tae Min
    Heo, Dae Seog
    Kim, Chul-Woo
    Jeon, Yoon Kyung
    MODERN PATHOLOGY, 2015, 28 : 353A - 353A
  • [35] Programmed Cell Death 1 and Programmed Cell Death Ligand 1 Expression in Extranodal NK/T-Cell Lymphoma
    Jung, Ho Young
    Kim, Wook Youn
    Kim, Tae Min
    Heo, Due Seog
    Kim, Chul-Woo
    Jeon, Yoon Kyung
    LABORATORY INVESTIGATION, 2015, 95 : 353A - 353A
  • [36] Programmed cell death protein 1 and vitiligo
    Lin, Xiran
    Meng, Xianmin
    Song, Zhiqi
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2019, 58 (09) : 1102 - 1103
  • [37] Programmed Cell Death Ligand 1 Expression in Osteosarcoma
    Shen, Jacson K.
    Cote, Gregory M.
    Choy, Edwin
    Yang, Pei
    Harmon, David
    Schwab, Joseph
    Nielsen, G. Petur
    Chebib, Ivan
    Ferrone, Soldano
    Wang, Xinhui
    Wang, Yangyang
    Mankin, Henry
    Hornicek, Francis J.
    Duan, Zhenfeng
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (07) : 690 - 698
  • [38] Risk monitoring and pharmacovigilance of programmed cell death protein 1/programmed cell death 1 ligand 1 in cancer patients after solid organ transplantation
    Mei, Long
    Li, Sa
    Fan, Qianqian
    Zhao, Bin
    Mei, Dan
    Took, Roxane
    Zhen, Jiancun
    THERAPIE, 2023, 78 (04): : 385 - 392
  • [39] Programmed Cell Death 1 Ligand 1 and Programmed Cell Death 1 Ligand 2 Are Expressed in Conjunctival Invasive Squamous Cell Carcinoma: Therapeutic Implications
    Wolkow, Natalie
    Jakobiec, Frederick A.
    Afrogheh, Amir H.
    Eagle, Ralph C., Jr.
    Pai, Sara, I
    Faquin, William C.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2019, 200 : 226 - 241
  • [40] Programmed death 1 and programmed death ligand 1 expressions in patients with chronic hepatitis B
    Wen-Jin Zhang
    Chuan-Hui Peng
    Shu-Sen Zheng
    Hepatobiliary & Pancreatic Diseases International, 2013, 12 (04) : 394 - 399
12345